Altimmune, Inc.ALTNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank71
3Y CAGR+3.4%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

3Y CAGR
+3.4%/yr
vs -28.3%/yr prior
Acceleration
+31.7pp
Accelerating
Percentile
P71
Within normal range
vs 3Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
202525.37%
202419.28%
20238.29%
202222.98%
2021-23.04%
2020-22.44%
201988.84%
201887.15%
2017-118.41%
2016-208.74%